Twist Bioscience Corporation

Twist Bioscience Corp.'s next confirmed earnings release is scheduled for November 13, 2026.

As of June 30, 2026, Twist Bioscience Corp. has 62.67M shares outstanding.

As of June 30, 2026, Twist Bioscience Corp. maintains a current ratio of 2.67, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Twist Bioscience Corp. posted a negative return on equity (ROE) of -29.59, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -20.78, reflecting losses generated across the asset base. The company generates approximately 386,060.05 in revenue per employee across its workforce of 979.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 6.79 indicates how many times Twist Bioscience Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Twist Bioscience Corp. recorded 756,259.20 in income tax expense. The company reported a pretax loss of -118.91M and -119.67M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, Twist Bioscience Corp. generated 377.95M in revenue and converted that into -119.67M in net income, yielding earnings per share of -1.95. EBITDA reached -104.67M, while operating income came in at -120.77M.

As of June 30, 2026, Twist Bioscience Corp. holds 146.03M in cash and equivalents against 81.92M in total debt, resulting in a net debt position of -102.79M. Total book value stands at 390.16M, with working capital of 175.97M providing operational flexibility.

Twist Bioscience Corp. produced -46.45M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -35.06M in capital expenditures, free cash flow totaled -81.51M - equivalent to -1.33 per share.

Over the twelve months ended June 30, 2026, Twist Bioscience Corp. posted a gross margin of 51.97, reflecting its pricing power and cost economics. The operating margin of -31.95 and net profit margin of -31.66 provide insight into operational efficiency.